4
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Chlamydia trachomatis serology screening in reproductive medicine

&
Pages 205-211 | Published online: 10 Jan 2014

References

  • Mardh PA. Tubal factor infertility, with special regard to chlamydial salpingitis. Curr. Opin. Infect. Dis.17, 49–52 (2004).
  • Land JA, Van Bergen JE, Morré SA, Postma MJ. Epidemiology of Chlamydia trachomatis infection in women and the cost–effectiveness of screening. Hum. Reprod. Update16(2), 189–204 (2010).
  • Gijsen AP, Land JA, Goossens VJ, Slobbe M, Bruggeman CA. Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time. Hum. Reprod.17(3), 699–703 (2002).
  • Kodaman P, Arici A, Seli E. Evidence-based diagnosis and management of tubal factor infertility. Curr. Opin. Obst. Gynecol.16, 221–229 (2004).
  • Land JA, Evers JL. Chlamydia infection and subfertility. Best Pract. Res. Clin. Obstet. Gynaecol.16(6), 901–912 (2002).
  • Thomas K, Coughlin L, Mannion PT, Haddad NG. The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations. Hum. Reprod.15(5), 1079–1082 (2000).
  • El Hakim EA, Gordon UD, Akande VA. The relationship between serum Chlamydia antibody levels and severity of disease in infertile women with tubal damage. Arch. Gynecol. Obstet.281(4), 727–733 (2010).
  • Rodgers AK, Wang J, Zhang Y et al. Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P. Am. J. Obstet. Gynecol.203(5), 494.e7–494.e14 (2010).
  • Minassian SS, Wu CH, Jungkind D, Gocial B, Filer RB, Glassner M. Chlamydial antibody, as determined with an enzyme-linked immunosorbent assay, in tubal factor infertility. J. Reprod. Med.35(2), 141–145 (1990).
  • Ridgway GL, Taylor-Robinson D. Current problems in microbiology: 1. Chlamydial infections: which laboratory test? J. Clin. Pathol.44(1), 1–5 (1991).
  • Cates W Jr, Wasserheit J. Genital chlamydial infections: epidemiology and reproductive sequelae. Am. J. Obstet. Gynecol.164(6), 1771–1778 (1991).
  • Bjercke S, Purvis K. Chlamydial serology in the investigation of infertility. Hum. Reprod.7(5), 621–624 (1992).
  • Czerwenka K, Heuss F, Hosmann J, Manavi M, Jelincic D, Kubista E. Salpingitis caused by Chlamydia trachomatis and its significance for infertility. Acta Obstet. Gynecol. Scand.73(9), 711–715 (1994).
  • Durante M, Keltz MD. Chlamydia trachomatis serology screening in infertility is a significant prognosticator of pregnancy in non-IVF cycles. Fertil. Steril.94(4), S13 (2010).
  • Karinen L, Pouta A, Hartikainen AL et al. Association between Chlamydia trachomatis antibodies and subfertility in the northern Finland birth cohort 1966 (NFBC 1966), at the age of 31 years. Epidemiol. Infect.132(5), 977–984 (2004).
  • Den Hartog JE, Morré SA, Land JA. Chlamydia trachomatis-associated tubal factor subfertility: immunogenetic aspects and serological screening. Hum. Reprod. Update.12(6), 719–730 (2006).
  • Land JA, Evers JL, Goossens VJ. How to use Chlamydia antibody testing in subfertility patients. Hum. Reprod.13(4), 1904–1908 (1998).
  • Punnonen R, Terho P, Nikkanen V, Meurman O. Chlamydial serology in infertile women by immunofluorescence. Fertil. Steril.31(6), 656–659 (1979).
  • Dowell SF, Peeling RW, Boman J et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis.33, 492–503 (2001).
  • Wang SP, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am. J. Ophthalmol.70(3), 367–374 (1970).
  • Clad A, Flecken E, Petersen E. Chlamydial serology in genital infections: immunocomb versus ipazyme. Infection21(6), 384–389 (1993).
  • Piura B, Sarov B, Sarov I. Persistence of antichlamydial antibodies after treatment of acute salpingitis with doxycycline. Eur. J. Obstet. Gynecol. Reprod. Biol.48(2), 117–121 (1993).
  • Rahm VA, Gnarpe H, Odlind V. Evaluation of a direct fluorescence assay as a screening method in asymptomatic young women. Sex. Transm. Dis.19(2), 84–87 (1992).
  • Henry-Suchet J, Askienazy-Elbhar M, Thibon M, Revol C, Akue BA. Post-therapeutic evolution of serum chlamydial antibody titers in women with acute salpingitis and tubal infertility. Fertil. Steril.62(2), 296–304 (1994).
  • Treharne JD, Darougar S, Jones BR. Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection. J. Clin. Pathol.30(6), 510–517 (1977).
  • Land JA, Gijsen AP, Kessels GH, Slobbe MEB, Bruggeman CA. Performance of five serological chlamydia antibody tests in subfertile women. Hum. Reprod.18(12), 2621–2627 (2003).
  • den Hartog JE, Land JA, Stassen FRM, Kessels AGH, Bruggeman CA. Serological markers of persistent C. trachomatis infections in women with tubal factor subfertility. Hum Reprod.20, 986–990 (2005).
  • Finn MP, Ohlin A, Schachter J. Enzyme-linked immunosorbent assay for immunoglobulin G and M antibodies to Chlamydia trachomatis in human sera. J. Clin. Microbiol. (5), 848–852 (1983).
  • Mouton JW, Peeters MF, van Rijssort-Vos JH, Verkooyen RP. Tubal factor pathology caused by Chlamydia trachomatis: the role of serology. Int. J. STD AIDS13(2), 26–29 (2002).
  • Paukku M, Tulppala M, Puolakkainen M, Anttila T, Paavonen J. Lack of association between serum antibodies to Chlamydia trachomatis and a history of recurrent pregnancy loss. Fertil. Steril.72(3), 427–430 (1992).
  • Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJ. Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog.5(8), e1000552 (2009).
  • Claman P, Honey L, Peeling RW, Jessamine P, Toye B. The presence of serum antibody to the chlamydial heat shock protein (CHSP60) as a diagnostic test for tubal factor infertility. Fertil. Steril.67(3), 501–504 (1997).
  • Toye B, Laferrière C, Claman P, Jessamine P, Peeling R. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J. Infect. Dis.168(5), 1236–1240 (1993).
  • Arno JN, Yuan Y, Cleary RE, Morrison RP. Serologic responses of infertile women to the 60-kD chlamydial heat shock protein (hsp60). Fertil. Steril.64(4), 730–735 (1995).
  • Paavonen J, Miettinen A, Heinonen PK et al. Serum CA 125 in acute pelvic inflammatory disease. Br. J. Obstet. Gynaecol.96(5), 574–579 (1989).
  • Bianchi M, Macaya R, Durruty G, Manzur A. Correlation between CA-125 marker with the presence and severity of pelvic endometriosis. Rev. Med. Chil.131(4), 367–372 (2003).
  • Mol BW, Bayram N, Lijmer JG et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil. Steril.70(6), 1101–1108 (1998).
  • Penninx J, Brandes M, de Bruin JP, Schneeberger PM, Hamilton CJ. Prediction of pelvic pathology in subfertile women with combined Chlamydia antibody and CA-125 tests. Eur. J. Obstet. Gynecol. Reprod. Biol.147(2), 178–182 (2009).
  • Ng EH, Tang OS, Ho PC. Measurement of serum CA-125 concentrations does not improve the value of Chlamydia trachomatis in predicting tubal pathology. Hum. Reprod.16(4), 775–779 (2001).
  • Phillips RS, Tuomala RE, Feldblum PJ, Schachter J, Rosenberg MJ, Aronson MD. The effect of cigarette smoking, Chlamydia trachomatis infection, and vaginal douching on ectopic pregnancy. Obstet. Gynecol.79(1), 85–90 (1992).
  • Tregoning SK, Ballard RC, Andersson PB, Fehler HG, van der Spuy ZM. Antibodies to Chlamydia trachomatis in patients presenting with ectopic pregnancy at Groote Schuur Hospital. S. Afr. Med. J.90(7), 727–730 (2000).
  • Odland JO, Anestad G, Rasmussen S, Lundgren R, Dalaker K. Ectopic pregnancy and chlamydial serology. Int. J. Gynaecol. Obstet.43(3), 271–275 (1993).
  • Buhaug H, Skjeldestad FE, Backe B, Dalen. A cost–effectiveness of testing for chlamydial infections in asymptomatic women. Med. Care27(8), 833–841 (1989).
  • Walters MD, Eddy CA, Gibbs RS, Schachter J, Holden AE, Pauerstein CJ. Antibodies to Chlamydia trachomatis and risk for tubal pregnancy. Am. J. Obstet. Gynecol.159(4), 942–946 (1988).
  • Stacey C, Munday P, Thomas B, Gilchrist C, Taylor-Robinson D, Beard R. Chlamydia trachomatis in the Fallopian tubes of women without laparoscopic evidence of salpingitis. Lancet336(8721), 960–963 (1990).
  • Chrysostomou M, Karafyllidi P, Papadimitriou V, Bassiotou V, Mayakos G. Serum antibodies to Chlamydia trachomatis in women with ectopic pregnancy, normal pregnancy or salpingitis. Eur. J. Obstet. Gynecol. Reprod. Biol.44, 101–105 (1992).
  • Svensson L, Mårdh PA, Ahlgren M, Nordenskjöld F. Ectopic pregnancy and antibodies to Chlamydia trachomatis. Fertil. Steril.44(3), 313–317 (1985).
  • Ault KA, Statland BD, King MM, Dozier DI, Joachims ML, Gunter J. Antibodies to the chlamydial 60 kilodalton heat shock protein in women with tubal factor infertility. Infect. Dis. Obstet. Gynecol.6(4), 163–167 (1988).
  • Keltz MD, Attar E, Buradagunta S, Olive DL, Kliman HJ, Arici A. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in the human Fallopian tube. Am. J. Obstet. Gynecol.175(6), 1611–1619 (1996).
  • Stirrat GM. Recurrent miscarriage. II: clinical associations, causes, and management. Lancet336(8717), 728–733 (1990).
  • Quinn PA, Petric M, Barkin M et al. Prevalence of antibody to Chlamydia trachomatis in spontaneous abortion and infertility. Am. J. Obstet. Gynecol.156(2), 291–296 (1987).
  • Licciardi F, Grifo A, Rosenwaks Z, Witkin S. Relation between antibodies to Chlamydia trachomatis and spontaneous abortion following in vitro fertilization. J. Assist. Reprod. Genet.9(3), 207–210 (1992).
  • Witkin SS, Ledger WJ. Antibodies to Chlamydia trachomatis in sera of women with recurrent spontaneous abortions. Am. J. Obstet. Gynecol.167(1), 135–139 (1992).
  • Osser S, Persson K. Chlamydial antibodies in women who suffer miscarriage. Br. J. Obstet. Gynaecol.103(2), 137–141 (1996).
  • Sozio J, Ness RB. Chlamydial lower genital tract infection and spontaneous abortion. Infect. Dis. Obstet. Gynecol.6(1), 8–12 (1998).
  • de Barbeyrac B, Papaxanthos-Roche A, Mathieu C et al.Chlamydia trachomatis in subfertile couples undergoing an in vitro fertilization program: a prospective study. J. Obstet. Gynecol. Reprod. Biol.129(1), 46–53 (2006).
  • Torode HW, Wheeler PA, Saunders DM, McPetrie RA, Medcalf SC, Ackerman VP. The role of chlamydial antibodies in an in vitro fertilization program. Fertil. Steril.48(6), 987–990 (1987).
  • Lessing JB, Kletter Y, Amster R, Amit A, Peyser MR, Berger S. Success rates in vitro fertilization treatment and its correlation with high titer antibodies for Chlamydia trachomatis. Israel J. Med. Sci.27(10), 546–549 (1991).
  • Driscoll GL, Dodd J, Tyler JP, Howard B, Lamont B, Coles R. Positive chlamydial serology and its effect on factors influencing outcome of IVF treatment. Aust. NZ J. Obstet. Gynaecol.31(2), 145–147 (1991).
  • Witkin SS, Sultan K, Neal G et al. Unsuspected Chlamydia trachomatis infection and in vitro fertilization outcome. Am. J. Obstet. Gynecol.171(5), 1208–1214 (1994).
  • Witkin SS, Kligman I, Grifo JA, Rosenwaks Z. Chlamydia trachomatis detected by polymerase chain reaction in cervices of culture-negative women correlates with adverse in vitro fertilization outcome. J. Infect. Dis.171(6), 1657–1659 (1995).
  • Tasdemir I, Tasdemir M, Kodama H, Sekine K, Tanaka TJ. Effect of chlamydial antibodies on the outcome of in vitro fertilization (IVF) treatment. Assist. Reprod. Genet.11(2), 104–106 (1994).
  • Spandorfer SD, Neuer A, LaVerda D et al. Previously undetected Chlamydia trachomatis infection, immunity to heat shock proteins and tubal occlusion in women undergoing in vitro fertilization. Hum. Reprod.14(1), 60–64 (1999).
  • Jakus S, Neuer A, Dieterle S, Bongiovanni AM, Witkin SS. Antibody to the Chlamydia trachomatis 60 kDa heat shock protein in follicular fluid and in vitro fertilization outcome. Am. J. Reprod. Immunol.59(2), 85–89 (2008).
  • Dabekausen YA, Evers JL, Land JA, Stals FS. Chlamydia trachomatis antibody testing is more accurate than hysterosalpingography in predicting tubal factor infertility. Fertil. Steril.61(5), 833–837 (1994).
  • Keltz MD, Gera PS, Moustakis M. Chlamydia serology screening in infertility patients. Fertil. Steril.85(3), 752–754 (2006).
  • Akande VA, Hunt LP, Cahill DJ, Caul EO, Ford WC, Jenkins JM. Tubal damage in infertile women: prediction using chlamydia serology. Hum. Reprod.18(9), 1841–1184 (2003).
  • Mol BWJ, DijkmanB, Wertheim P et al. The accuracy of serum chlamydial antibodies in the the diagnosis of tubal pathology; a meta-analysis. Fertil. Steril.67, 1031–1037 (1997).
  • Veenemans LM, van der Linden PJ. The value of Chlamydia trachomatis antibody testing in predicting tubal factor infertility. Hum. Reprod.17, 695–698 (2002).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.